‘This is pharma’s dream’: How drugmakers are turning telehealth into a marketing gold mine

“Talk to a Doctor Now:” A look on how drug makers are cashing in on telehealth

Making medications more accessible to support desirable therapeutic outcomes and adherence has been a long-standing goal of both Pharma and providers. However, leveraging technology, especially ad hoc or on-demand virtual care visits for this purpose is controversial on several levels. STAT reporting highlights both the potential benefits and the questions about this practice.